Molecular features crucial to the activity of pyrimidine benzamide-based thrombopoietin receptor agonists
- 1 May 2008
- journal article
- research article
- Published by Elsevier in Bioorganic & Medicinal Chemistry Letters
- Vol. 18 (9) , 3000-3006
- https://doi.org/10.1016/j.bmcl.2008.03.052
Abstract
No abstract availableKeywords
This publication has 38 references indexed in Scilit:
- Hot-spot mimicry of a cytokine receptor by a small moleculeProceedings of the National Academy of Sciences, 2006
- Between a rock and a hard place?Nature Chemical Biology, 2006
- Strategies for Targeting Protein–Protein Interactions With Synthetic AgentsAngewandte Chemie International Edition in English, 2005
- Identification of nonpeptidic small-molecule inhibitors of interleukin-2Bioorganic & Medicinal Chemistry Letters, 2005
- Functional analysis of the interleukin-5 receptor antagonist peptide, AF18748Cytokine, 2004
- Integrating Fragment Assembly and Biophysical Methods in the Chemical Advancement of Small-Molecule Antagonists of IL-2: An Approach for Inhibiting Protein−Protein InteractionsJournal of Medicinal Chemistry, 2004
- Molecular Phylogeny within Type I Cytokines and Their Cognate ReceptorsImmunity, 2003
- Discovery of a Potent Small Molecule IL-2 Inhibitor through Fragment AssemblyJournal of the American Chemical Society, 2003
- Development of IL-5 Receptor AntagonistsCurrent Pharmaceutical Design, 2002
- Identification of a Small Molecule Inhibitor of the IL-2/IL-2Rα Receptor Interaction Which Binds to IL-2Journal of the American Chemical Society, 1997